Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 21, 2026 04:49 ET | Source: Research and Markets

Bispecific Antibody Drug Conjugates Market Landscape Report 2026: A $2 Billion Opportunity by 2030 with the 1st Approved BsADC by 2028 - Clinical Trials, Regulatory Approvals, Development Platforms

Dublin, April 21, 2026 (GLOBE NEWSWIRE) -- The "Bispecific Antibody Drug Conjugates Clinical Trials, Regulatory Approvals, Development Platforms & Market Opportunity Insight 2026" report has...
April 21, 2026 04:40 ET | Source: Royal UNIBREW A/S

Q1 2026 trading statement

COMPANY ANNOUNCEMENT NO 18/2026 - April 21, 2026 EBIT up 25% in Q1 2026 driven by solid commercial performance and margin expansion Key Highlights Q1 2026 Market share gains and solid commercial...
April 21, 2026 04:36 ET | Source: Prosafe SE

Prosafe SE: Operational update – March 2026

21 April 2026 - Fleet utilisation for March 2026 was 42% and 79% in first quarter. In Brazil, Safe Eurus continued to operate at full capacity in March, delivering near 100 % commercial uptime. ...
April 21, 2026 04:34 ET | Source: Research and Markets

Bispecific Antibody Market Landscape Report 2026: A Potential $60 Opportunity by 2031 - Insight on More than 550 Clinical Trials - Antibody Dosage, Patent, Price, Sales & Outlook

Dublin, April 21, 2026 (GLOBE NEWSWIRE) -- The "Bispecific Antibody Market Opportunity, Antibody Dosage, Patent, Price, Sales & Clinical Trials Outlook 2031" report has been added to ...
April 21, 2026 04:31 ET | Source: Research and Markets

Peptide Drug Conjugate Market Landscape Report 2026: A $1.5 Billion Opportunity by 2031 - Drug Sales, Patent, Price, Dosage, Proprietary Technologies & Outlook

Dublin, April 21, 2026 (GLOBE NEWSWIRE) -- The "Peptide Drug Conjugate Market Opportunity, Drug Sales, Patent, Price, Dosage, Proprietary Technologies & Clinical Trials Outlook 2031" report has...
April 21, 2026 04:27 ET | Source: Research and Markets

Targeted Alpha Therapy Market Landscape Report 2026-2030: Clinical Trials Insights on 30 Drugs - Size, Regulatory Approvals, Proprietary Technologies, Therapeutic Applications

Dublin, April 21, 2026 (GLOBE NEWSWIRE) -- The "Targeted Alpha Therapy Market Size, Regulatory Approvals, Proprietary Technologies, Therapeutic Applications & Clinical Trials Insight 2030"...
April 21, 2026 04:15 ET | Source: Canaccord Genuity Wealth Limited

Form 8.3 - [ADVANCED MEDICAL SOLUTIONS PLC - 20 04 2026] - (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY...
April 21, 2026 04:15 ET | Source: Sveriges Riksbank

RESULT OF RIKSBANK CERTIFICATE SALE

AuctionAuction resultsAuction date2026-04-21Start date2026-04-22Maturity date2026-04-29Interest rate1.75 %Offered volume, SEK bn512.0Total bid amount, SEK bn400.8Accepted volume, SEK bn400.8Number of...
April 21, 2026 04:14 ET | Source: Research and Markets

Oncolytic Virus Immunotherapy Market Landscape Report 2026: A $5 Opportunity by 2031 - Technology Platforms, Approved Therapy Dosage, Price & Clinical Trials Insights

Dublin, April 21, 2026 (GLOBE NEWSWIRE) -- The "Oncolytic Virus Immunotherapy Market Opportunity, Technology Platforms, Approved Therapy Dosage, Price & Clinical Trials Insight 2031" report has...
April 21, 2026 04:13 ET | Source: Canaccord Genuity Wealth Limited

Form 8.3 - [IDOX PLC - 20 04 2026] - (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY...